APA (7th ed.) Citation

THW, C., R, G., C, B., SA, K., G, D., E, D., . . . B, K. (2023). Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: Protocol for a randomized, double-blind, placebo-controlled, non-crossover trial. Frontiers in psychiatry, 14, 1178529. https://doi.org/10.3389/fpsyt.2023.1178529

Chicago Style (17th ed.) Citation

THW, Ching, et al. "Safety, Tolerability, and Clinical and Neural Effects of Single-dose Psilocybin in Obsessive-compulsive Disorder: Protocol for a Randomized, Double-blind, Placebo-controlled, Non-crossover Trial." Frontiers in Psychiatry 14 (2023): 1178529. https://doi.org/10.3389/fpsyt.2023.1178529.

MLA (9th ed.) Citation

THW, Ching, et al. "Safety, Tolerability, and Clinical and Neural Effects of Single-dose Psilocybin in Obsessive-compulsive Disorder: Protocol for a Randomized, Double-blind, Placebo-controlled, Non-crossover Trial." Frontiers in Psychiatry, vol. 14, 2023, p. 1178529, https://doi.org/10.3389/fpsyt.2023.1178529.